Gapping up
In reaction to earnings/guidance:
- PERI +8.4% (guidance), COTY +0.6% (guidance)
Other news:
- GENI +12.6% (Genius Sports and NFL agreed to a multi-year extension of their existing strategic partnership)
- VSTM +4.7% (announces design for confirmatory trial of Avutometinib and Defactinib)
- MITK +4.6% (provides from Nasdaq)
- MARA +4.4% (reports it produced 979 BTC in June 2023 and 5120 BTC year-to-date)
- BANC +3.4% (appoints Joseph Kauder as Executive Vice President and Chief Financial Officer of the Company and the Bank effective July 10 2023)
- BITF +3% (starts production at Baie-Comeau and increases hashrate target to 6.3 EH/s in Q3)
- NKLA +2.8% (awarded $41.9 mln grant by California to build refueling stations)
- MRUS +2.8% (FDA grants second Breakthrough Therapy Designation for Zenocutuzumab)
- SAVE +2.7% (JBLU issues statement on Northeast Alliance with AAL; disagrees with court ruling but does not plan to appeal; JBLU will now turn even more focus to proposed combination with SAVE)
- HUT +2.5% (reports it generated 120 Bitcoin in June)
- ASLN +2.4% (to discuss Phase 2b topline data from TREK-AD trial)
- SVM +2.1% (reports high-grade silver-lead drill results)
- FIS +2% (accelerates path to create two highly focused independent companies; announces agreement for GTCR to acquire majority stake in Worldpay at $18.5 bln valuation)
- LUNR +1.2% (stock offering by selling shareholder)
- ACT +1.1% (entered into quota share reinsurance agreement)
Analyst comments:
- KDP +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ASB +1.2% (upgraded to Outperform from Mkt Perform at Raymond James)
- FHN +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)